ArticleJournal of experimental & clinical cancer research : CR2022
Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).
Lin Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.